{"entity":{"type":"insider","cik":"0001845804","url":"/insider/0001845804","json_url":"/insider/0001845804.json","name":"OrbiMed Capital GP VIII LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":95,"n_filings":30,"first":"2021-02-19","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP VIII LLC","source":"filing","n_filings":30,"first_seen":"2021-02-19","last_seen":"2026-08-12"}],"transactions":[{"id":9211163,"accession":"0000947871-26-000784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000784","line_url":"/filing/0000947871-26-000784#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"BlossomHill Therapeutics, Inc.","issuer_ticker":"BLSM","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":2714279.0,"shares_owned_after_display":"2,714,279","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":5781087,"accession":"0000947871-26-000733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000733","line_url":"/filing/0000947871-26-000733#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":1348825.0,"shares_owned_after_display":"1,348,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":5901688,"accession":"0000947871-26-000694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000694","line_url":"/filing/0000947871-26-000694#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85918.0,"shares_display":"85,918","price_per_share":44.86,"price_display":"44.86","price_state":"stated","total_value":3854281.48,"total_display":"3,854,281.48","total_whole":"3,854,281","shares_owned_after":2469959.0,"shares_owned_after_display":"2,469,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider"},{"id":5880007,"accession":"0000947871-26-000683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000683","line_url":"/filing/0000947871-26-000683#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115844.0,"shares_display":"115,844","price_per_share":45.5,"price_display":"45.50","price_state":"stated","total_value":5270902.0,"total_display":"5,270,902.00","total_whole":"5,270,902","shares_owned_after":2555877.0,"shares_owned_after_display":"2,555,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":5768398,"accession":"0000947871-26-000587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000587","line_url":"/filing/0000947871-26-000587#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":4493.49,"total_display":"4,493.49","total_whole":"4,493","shares_owned_after":2671721.0,"shares_owned_after_display":"2,671,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-27","filed_date":"2026-05-29","scope":"insider"},{"id":5937339,"accession":"0000947871-26-000517","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000517","line_url":"/filing/0000947871-26-000517#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184639.0,"shares_display":"184,639","price_per_share":46.22,"price_display":"46.22","price_state":"stated","total_value":8534014.58,"total_display":"8,534,014.58","total_whole":"8,534,015","shares_owned_after":2671822.0,"shares_owned_after_display":"2,671,822","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider"},{"id":5937336,"accession":"0000947871-26-000517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000517","line_url":"/filing/0000947871-26-000517#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59767.0,"shares_display":"59,767","price_per_share":44.58,"price_display":"44.58","price_state":"stated","total_value":2664412.86,"total_display":"2,664,412.86","total_whole":"2,664,413","shares_owned_after":2856461.0,"shares_owned_after_display":"2,856,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider"},{"id":5937333,"accession":"0000947871-26-000517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000517","line_url":"/filing/0000947871-26-000517#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48546.0,"shares_display":"48,546","price_per_share":44.61,"price_display":"44.61","price_state":"stated","total_value":2165637.06,"total_display":"2,165,637.06","total_whole":"2,165,637","shares_owned_after":2916228.0,"shares_owned_after_display":"2,916,228","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider"},{"id":6052164,"accession":"0000947871-26-000458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000458","line_url":"/filing/0000947871-26-000458#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2948.0,"shares_display":"2,948","price_per_share":44.52,"price_display":"44.52","price_state":"stated","total_value":131244.96,"total_display":"131,244.96","total_whole":"131,245","shares_owned_after":2964774.0,"shares_owned_after_display":"2,964,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-18","filed_date":"2026-04-21","scope":"insider"},{"id":6052161,"accession":"0000947871-26-000458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000458","line_url":"/filing/0000947871-26-000458#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52397.0,"shares_display":"52,397","price_per_share":44.68,"price_display":"44.68","price_state":"stated","total_value":2341097.96,"total_display":"2,341,097.96","total_whole":"2,341,098","shares_owned_after":2967722.0,"shares_owned_after_display":"2,967,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":6146365,"accession":"0000947871-26-000481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000481","line_url":"/filing/0000947871-26-000481#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Traws Pharma, Inc.","issuer_ticker":"TRAW","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":597729.0,"shares_display":"597,729","price_per_share":1.67,"price_display":"1.67","price_state":"stated","total_value":998207.43,"total_display":"998,207.43","total_whole":"998,207","shares_owned_after":1203250.0,"shares_owned_after_display":"1,203,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-28","scope":"insider"},{"id":6146362,"accession":"0000947871-26-000446","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000446","line_url":"/filing/0000947871-26-000446#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226906.0,"shares_display":"226,906","price_per_share":45.34,"price_display":"45.34","price_state":"stated","total_value":10287918.04,"total_display":"10,287,918.04","total_whole":"10,287,918","shares_owned_after":3020119.0,"shares_owned_after_display":"3,020,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-16","scope":"insider"},{"id":6146359,"accession":"0000947871-26-000446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000446","line_url":"/filing/0000947871-26-000446#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235863.0,"shares_display":"235,863","price_per_share":44.64,"price_display":"44.64","price_state":"stated","total_value":10528924.32,"total_display":"10,528,924.32","total_whole":"10,528,924","shares_owned_after":3247025.0,"shares_owned_after_display":"3,247,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-16","scope":"insider"},{"id":6146356,"accession":"0000947871-26-000446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000446","line_url":"/filing/0000947871-26-000446#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47814.0,"shares_display":"47,814","price_per_share":44.51,"price_display":"44.51","price_state":"stated","total_value":2128201.14,"total_display":"2,128,201.14","total_whole":"2,128,201","shares_owned_after":3482888.0,"shares_owned_after_display":"3,482,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-16","scope":"insider"},{"id":6191040,"accession":"0000947871-26-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000088","line_url":"/filing/0000947871-26-000088#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29063.0,"shares_display":"29,063","price_per_share":44.58,"price_display":"44.58","price_state":"stated","total_value":1295628.54,"total_display":"1,295,628.54","total_whole":"1,295,629","shares_owned_after":3530702.0,"shares_owned_after_display":"3,530,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":6191034,"accession":"0000947871-26-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000088","line_url":"/filing/0000947871-26-000088#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1890.0,"shares_display":"1,890","price_per_share":44.57,"price_display":"44.57","price_state":"stated","total_value":84237.3,"total_display":"84,237.30","total_whole":"84,237","shares_owned_after":3559765.0,"shares_owned_after_display":"3,559,765","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4414656,"accession":"0000947871-25-001096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001096","line_url":"/filing/0000947871-25-001096#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33356.0,"shares_display":"33,356","price_per_share":44.55,"price_display":"44.55","price_state":"stated","total_value":1486009.8,"total_display":"1,486,009.80","total_whole":"1,486,010","shares_owned_after":3561655.0,"shares_owned_after_display":"3,561,655","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-29","scope":"insider"},{"id":4338755,"accession":"0000947871-25-001088","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-001088","line_url":"/filing/0000947871-25-001088#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":38928.75,"total_display":"38,928.75","total_whole":"38,929","shares_owned_after":3595011.0,"shares_owned_after_display":"3,595,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-19","scope":"insider"},{"id":4338750,"accession":"0000947871-25-001088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-001088","line_url":"/filing/0000947871-25-001088#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":4449.0,"total_display":"4,449.00","total_whole":"4,449","shares_owned_after":3595886.0,"shares_owned_after_display":"3,595,886","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":4338744,"accession":"0000947871-25-001088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001088","line_url":"/filing/0000947871-25-001088#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":44.5,"price_display":"44.50","price_state":"stated","total_value":40050.0,"total_display":"40,050.00","total_whole":"40,050","shares_owned_after":3595986.0,"shares_owned_after_display":"3,595,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":4488952,"accession":"0000947871-25-001045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-001045","line_url":"/filing/0000947871-25-001045#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":71184.0,"total_display":"71,184.00","total_whole":"71,184","shares_owned_after":3596886.0,"shares_owned_after_display":"3,596,886","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-11-26","scope":"insider"},{"id":4488948,"accession":"0000947871-25-001045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-001045","line_url":"/filing/0000947871-25-001045#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11890.0,"shares_display":"11,890","price_per_share":44.6,"price_display":"44.60","price_state":"stated","total_value":530294.0,"total_display":"530,294.00","total_whole":"530,294","shares_owned_after":3598486.0,"shares_owned_after_display":"3,598,486","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4488945,"accession":"0000947871-25-001045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001045","line_url":"/filing/0000947871-25-001045#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94583.0,"shares_display":"94,583","price_per_share":44.54,"price_display":"44.54","price_state":"stated","total_value":4212726.82,"total_display":"4,212,726.82","total_whole":"4,212,727","shares_owned_after":3610376.0,"shares_owned_after_display":"3,610,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4453815,"accession":"0000947871-25-000345","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5738.0,"shares_display":"5,738","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":310483.18,"total_display":"310,483.18","total_whole":"310,483","shares_owned_after":746171.0,"shares_owned_after_display":"746,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider","n_lines":3},{"id":4453796,"accession":"0000947871-25-000333","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10011.0,"shares_display":"10,011","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":540594.0,"total_display":"540,594.00","total_whole":"540,594","shares_owned_after":749197.0,"shares_owned_after_display":"749,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider","n_lines":3},{"id":4453776,"accession":"0000947871-25-000333","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2762.0,"shares_display":"2,762","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":149175.62,"total_display":"149,175.62","total_whole":"149,176","shares_owned_after":754476.0,"shares_owned_after_display":"754,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider","n_lines":3},{"id":4453743,"accession":"0000947871-25-000333","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39656.0,"shares_display":"39,656","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":2142217.12,"total_display":"2,142,217.12","total_whole":"2,142,217","shares_owned_after":755933.0,"shares_owned_after_display":"755,933","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider","n_lines":3},{"id":4699253,"accession":"0000947871-25-000308","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83182.0,"shares_display":"83,182","price_per_share":54.452972638311174,"price_display":"54.45","price_state":"stated","total_value":4529507.17,"total_display":"4,529,507.17","total_whole":"4,529,507","shares_owned_after":776844.0,"shares_owned_after_display":"776,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider","n_lines":6},{"id":4699220,"accession":"0000947871-25-000308","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27056.0,"shares_display":"27,056","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":1461294.56,"total_display":"1,461,294.56","total_whole":"1,461,295","shares_owned_after":820707.0,"shares_owned_after_display":"820,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider","n_lines":3},{"id":4699199,"accession":"0000947871-25-000308","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202146.0,"shares_display":"202,146","price_per_share":54.29142471283132,"price_display":"54.29","price_state":"stated","total_value":10974794.34,"total_display":"10,974,794.34","total_whole":"10,974,794","shares_owned_after":835185.0,"shares_owned_after_display":"835,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":"2025-03-10|4699168","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001839970","name":"BlossomHill Therapeutics, Inc.","url":"/issuer/0001839970","role":"Director","n_filings":1,"first_seen":"2026-08-12","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001853921","name":"Scribe Therapeutics, Inc.","url":"/issuer/0001853921","role":"Director","n_filings":1,"first_seen":"2026-07-29","last_seen":"2026-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Director","n_filings":11,"first_seen":"2025-02-10","last_seen":"2026-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001130598","name":"Traws Pharma, Inc.","url":"/issuer/0001130598","role":"Ten percent owner","n_filings":1,"first_seen":"2026-04-28","last_seen":"2026-04-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2023-02-17","last_seen":"2025-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0002022626","name":"Upstream Bio, Inc.","url":"/issuer/0002022626","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-10-17","last_seen":"2024-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001868279","name":"ArriVent Biopharma, Inc.","url":"/issuer/0001868279","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-01-31","last_seen":"2024-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001797768","name":"Kinnate Biopharma Inc.","url":"/issuer/0001797768","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2023-05-02","last_seen":"2023-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Director","n_filings":3,"first_seen":"2021-06-16","last_seen":"2021-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001656536","name":"Decibel Therapeutics, Inc.","url":"/issuer/0001656536","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2021-02-19","last_seen":"2021-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001845804","retrieved_at":"2026-08-25T19:12:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}